Gene: CD248
Official Full Name: CD248 moleculeprovided by HGNC
Gene Summary: Predicted to enable extracellular matrix binding activity and extracellular matrix protein binding activity. Predicted to be involved in cell migration. Predicted to act upstream of or within several processes, including fibroblast migration; lymph node development; and positive regulation of endothelial cell apoptotic process. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA08199 | CD248 Knockout cell line (AC16) | Human | CD248 | 1:3-1:4 | negative | Online Inquiry |
| KOA23643 | CD248 Knockout cell line (BEAS-2B) | Human | CD248 | 1:3~1:4 | negative | Online Inquiry |
| KOA39093 | CD248 Knockout cell line (U-2932) | Human | CD248 | 1:2-1:4 | negative | Online Inquiry |
| KOA54487 | CD248 Knockout cell line (TPC-1) | Human | CD248 | 1:5-1:8 | negative | Online Inquiry |
| KOA69898 | CD248 Knockout cell line (NCM460) | Human | CD248 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.